bexarotene has been researched along with Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiNardo, CD; Forfia, P; Ky, B; Loren, A; Luger, S; Mato, A; Tsai, DE; Vogl, DT | 1 |
1 other study(ies) available for bexarotene and Syndrome
| Article | Year |
|---|---|
Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
Topics: Antineoplastic Agents; Bexarotene; Cell Differentiation; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pericardial Effusion; Retinoid X Receptors; Syndrome; Tetrahydronaphthalenes | 2008 |